Kentucky House Bill 71 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 7 2020 - 25% progression, died in committee
Action: 2020-01-07 - to Health and Family Services (H)
Pending: House Health and Family Services Committee
Text: Latest bill text (Introduced) [PDF]

Create a new section of KRS Chapter 218A to require a practitioner to offer a prescription for naloxone hydrochloride or another drug approved by the Food and Drug Administration for the complete or partial reversal of opioid depression when prescribing an opioid drug and to provide education on overdose prevention and on use of an opioid depression reversal drug; amend KRS 218A.172 to delete reference to Schedule III controlled substances containing hydrocodone and to add issues that a practitioner is required to discuss with a patient prior to prescribing or dispensing a controlled substance to a patient; amend KRS 205.529, 218A.205, and 304.17A-165 to delete reference to Schedule III controlled substances containing hydrocodone.

AN ACT relating to controlled substances.

Rep. Danny Bentley [R]

Date	Chamber	Action
2020-01-07	House	to Health and Family Services (H)
2020-01-07	House	introduced in House
2019-10-24	House	Prefiled by the sponsor(s).

Type	Source
Summary	https://apps.legislature.ky.gov/record/20RS/hb71.html
Text	https://apps.legislature.ky.gov/recorddocuments/bill/20RS/hb71/orig_bill.pdf